These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 26234760)

  • 1. Gut permeability, its interaction with gut microflora and effects on metabolic health are mediated by the lymphatics system, liver and bile acid.
    Tran CD; Grice DM; Wade B; Kerr CA; Bauer DC; Li D; Hannan GN
    Future Microbiol; 2015; 10(8):1339-53. PubMed ID: 26234760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early life events influence whole-of-life metabolic health via gut microflora and gut permeability.
    Kerr CA; Grice DM; Tran CD; Bauer DC; Li D; Hendry P; Hannan GN
    Crit Rev Microbiol; 2015; 41(3):326-40. PubMed ID: 24645635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the gut microbiota in NAFLD.
    Leung C; Rivera L; Furness JB; Angus PW
    Nat Rev Gastroenterol Hepatol; 2016 Jul; 13(7):412-25. PubMed ID: 27273168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut.
    Ridlon JM; Kang DJ; Hylemon PB; Bajaj JS
    Dig Dis; 2015; 33(3):338-45. PubMed ID: 26045267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota changes and chronic hepatitis C virus infection.
    Preveden T; Scarpellini E; Milić N; Luzza F; Abenavoli L
    Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):813-819. PubMed ID: 28621554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Microbiome in Mental Health: Potential Contribution of Gut Microbiota in Disease and Pharmacotherapy Management.
    Flowers SA; Ellingrod VL
    Pharmacotherapy; 2015 Oct; 35(10):910-6. PubMed ID: 26497477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alteration of intestinal permeability: the missing link between gut microbiota modifications and inflammation in obesity?].
    Genser L; Poitou C; Brot-Laroche É; Rousset M; Vaillant JC; Clément K; Thenet S; Leturque A
    Med Sci (Paris); 2016 May; 32(5):461-9. PubMed ID: 27225918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?
    Brandl K; Schnabl B
    Expert Rev Gastroenterol Hepatol; 2015; 9(8):1069-76. PubMed ID: 26088524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut-liver axis.
    Visschers RG; Luyer MD; Schaap FG; Olde Damink SW; Soeters PB
    Curr Opin Clin Nutr Metab Care; 2013 Sep; 16(5):576-81. PubMed ID: 23873346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and alcoholic liver disease.
    Stärkel P; Leclercq S; de Timary P; Schnabl B
    Clin Sci (Lond); 2018 Jan; 132(2):199-212. PubMed ID: 29352076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of gut barrier and gut microbiota in food restriction, food deprivation and protein-energy wasting.
    Genton L; Cani PD; Schrenzel J
    Clin Nutr; 2015 Jun; 34(3):341-9. PubMed ID: 25459400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
    Frazier TH; DiBaise JK; McClain CJ
    JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the human intestinal microbiome on obesity and metabolic dysfunction.
    Tilg H; Adolph TE
    Curr Opin Pediatr; 2015 Aug; 27(4):496-501. PubMed ID: 26087428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile Acid Modifications at the Microbe-Host Interface: Potential for Nutraceutical and Pharmaceutical Interventions in Host Health.
    Joyce SA; Gahan CG
    Annu Rev Food Sci Technol; 2016; 7():313-33. PubMed ID: 26772409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal neuromuscular apparatus: An underestimated target of gut microbiota.
    Guarino MP; Cicala M; Putignani L; Severi C
    World J Gastroenterol; 2016 Dec; 22(45):9871-9879. PubMed ID: 28018095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Gut-Liver Axis in the Control of Energy Metabolism and Food Intake in Animals.
    Ringseis R; Gessner DK; Eder K
    Annu Rev Anim Biosci; 2020 Feb; 8():295-319. PubMed ID: 31689373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota and its pathophysiology in disease paradigms.
    Festi D; Schiumerini R; Birtolo C; Marzi L; Montrone L; Scaioli E; Di Biase AR; Colecchia A
    Dig Dis; 2011; 29(6):518-24. PubMed ID: 22179206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoids--at the crossroads between the gut microbiota and host metabolism.
    Cani PD; Plovier H; Van Hul M; Geurts L; Delzenne NM; Druart C; Everard A
    Nat Rev Endocrinol; 2016 Mar; 12(3):133-43. PubMed ID: 26678807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.